| Literature DB >> 27248438 |
David Hanwell1, Sarah A Hutchinson2, Chereen Collymore3, Ashley E Bruce4, Rhain Louis1, Ayoob Ghalami5, W Ted Allison6, Marc Ekker7, B Frank Eames8, Sarah Childs9, Deborah M Kurrasch10, Robert Gerlai4,11, Tod Thiele4,12, Ian Scott13, Brian Ciruna13, James J Dowling14, Sarah McFarlane9, Peng Huang9, Xiao-Yan Wen15, Marie-Andrée Akimenko7, Andrew J Waskiewicz16, Pierre Drapeau17, Lorne A Babiuk18, Dan Dragon19, Andrea Smida20, Andre Gerald Buret21, Eoin O'Grady22, Joanna Wilson23, Lois Sowden-Plunkett24, Vincent Tropepe4.
Abstract
The zebrafish model system is helping researchers improve the health and welfare of people and animals and has become indispensable for advancing biomedical research. As genetic engineering is both resource intensive and time-consuming, sharing successfully developed genetically modified zebrafish lines throughout the international community is critical to research efficiency and to maximizing the millions of dollars in research funding. New restrictions on importation of zebrafish into Canada based on putative susceptibility to infection by the spring viremia of carp virus (SVCV) have been imposed on the scientific community. In this commentary, we review the disease profile of SVCV in fish, discuss the findings of the Canadian government's scientific assessment, how the interpretations of their assessment differ from that of the Canadian research community, and describe the negative impact of these regulations on the Canadian research community and public as it pertains to protecting the health of Canadians.Entities:
Mesh:
Year: 2016 PMID: 27248438 DOI: 10.1089/zeb.2016.1286
Source DB: PubMed Journal: Zebrafish ISSN: 1545-8547 Impact factor: 1.985